Last Wednesday (02), through a statement, the Union Cycliste Internationale (UCI) announced that Robert Stannard, from the Alpecin-Deceuninck team, is provisionally suspended on suspicion of having violated the anti-doping rules between 2018 and 2019. Thus, the cyclist will not be able to participate in the World Championships in Glasgow.
Immediately upon being communicated by the UCI, Robert Stannard’s agents, Signature Sport, shared on social networks denying the information claiming surprise: “I have been notified by the Union Cycliste Internationale (UCI) that it considers that I committed an anti-doping rule violation more than four years ago”.
The cyclist continued: “I have never intentionally or knowingly used a prohibited substance and will therefore ask that my case be referred to the UCI Anti-Doping Tribunal. I look forward to presenting my defense and I am confident of being exonerated and continuing my career”.
At the same time, his current team spoke about the information pointed out by the institution, stating that the mentioned case occurred before the cyclist joined the team and that he will wait for the continuation of the case. Alpecin-Deceuninck also noted that its contract ends this year and did not express the possibility of renewal.
Recently, when checking the blood samples of one of the competitions on the official calendar, Giro d’Italia, the UCI commented that 64 signs of the presence of the substance found in the drug Tramadol were found, as was the case of the athlete Alex Baudin, of AG2R Citroen .
Despite not being considered a form of doping, the use of the drug was banned by the UCI in March 2019 due to the side effects of its ingestion, which could affect the performance of athletes, such as increased drowsiness, nausea, dizziness, indigestion, among others. others.